Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Nutrition & Dietetics Volume 4 (2018), Article ID 4:IJCND-136, 6 pages
https://doi.org/10.15344/2456-8171/2018/136
Research Article
Omega-3 Fatty Acids Insufficiency in Post Traumatic Brain Injury Patient (TBI) Attending Neurosurgery Clinics at Khola Hospital in Muscat- Sultanate of Oman

Ghazi Daradkeh1,2,5,*, Musthafa Mohamed Essa1,2, Ali AL- Maashani4, Samir Al-Adawi2,3, R. Koshi2, Sameera AL-Abrawi4, Rayan Amiri4 and Jokha Al Barashdi4

1Department of Food Science and Nutrition, College of Agricultural and Marine Sciences, Sultan Qaboos University, Oman.
2Ageing and Dementia Research Group, Sultan Qaboos University, Oman
3Department of Behavioural Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, Oman
4Khoula Hospital, Ministry of Health, Oman
5Hamad Medical Corporation, Qatar
Dr. Ghazi Daradkeh, Department of Dietetics and Clinical Nutrition, Al-Khor Hospital, Hamad Medical Corporation, Qatar, Tel: +974 5526 4714; E-mail: gdaradkeh@hamad.qa
21 September 2018; 20 October 2018; 22 October 2018
Daradkeh G, Essa MM, AL-Maashani A, Al-Adawi S, Koshi R, et al. (2018) Omega-3 Fatty Acids Insufficiency in Post Traumatic Brain Injury Patient (TBI) Attending Neurosurgery Clinics at Khola Hospital in Muscat- Sultanate of Oman. Int J Clin Nutr Diet 4: 136. doi: https://doi.org/10.15344/2456-8171/2018/136
© 2018 Daradkeh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Warden D (2006) Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil 21: 398-402 [Google Scholar] [PubMed]
  2. Langlois JA, Rutland-Brown W, Wald MM (2006) The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 21: 375-378 [Google Scholar] [PubMed]
  3. Centers for Disease Control and Prevention (2007) Nonfatal Traumatic Brain Injuries from Sports and Recreation Activities - United States 2001-2005. MMWR Morb Mortal Wkly Rep 56: 733-737 [Google Scholar] [PubMed]
  4. Omalu BI, DeKosky ST, Hamilton RL, Minster RL, Kamboh MI, et al. (2006) Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery 59: 1086-1092 [CrossRef] [Google Scholar] [PubMed]
  5. Guskiewicz KM, Marshall SW, Bailes J, McCrea M, Harding HP, et al. (2007) Recurrent concussion and risk of depression in retired professional football players. Med Sci Sports Exerc 39: 903-909 [CrossRef] [Google Scholar] [PubMed]
  6. Omalu BI, Bailes J, Hammers JL, Fitzsimmons RP (2010) Chronic traumatic encephalopathy, suicides, and parasuicides in professional American athletes: the role of the forensic pathologist. Am J Forensic Med Pathol 31: 130-132 [CrossRef] [Google Scholar] [PubMed]
  7. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, et al. (2012) Neuroprotective effect of natural products against Alzheimer's disease. Neurochem Res 37: 1829-1842 [CrossRef] [Google Scholar] [PubMed]
  8. du Bois TM, Deng C, Bell W, Huang XF (2006) Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 139: 1397-1403 [CrossRef] [Google Scholar] [PubMed]
  9. Wu A, Ying Z, Gomez-Pinilla F (2008) Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 155: 751-759 [CrossRef] [Google Scholar] [PubMed]
  10. Lang-Lazdunski L, Blondeau N, Jarretou G, Lazdunski M, Heurteaux C, et al. (2003) Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats. J Vasc Surg; 38: 564-575 [CrossRef] [Google Scholar] [PubMed]
  11. Wu A, Ying Z, Gomez-Pinilla F (2004) Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21: 1457-1467 [CrossRef] [Google Scholar] [PubMed]
  12. Wu A, Ying Z, Gomez-Pinilla F (2011) The salutary effects of DHA dietary Supplementation on cognition, neuroplasticity, and membrane homeostasis after brain Trauma. J Neurotrauma 28: 2113-2122 [CrossRef] [Google Scholar] [PubMed]
  13. Mills JD, Bailes JE, Sedney CL, Hutchins H, Sears B, et al. (2011) Omega-3 fatty acid Supplementation and reduction of traumatic axonal injury in a rodent head injury model. J Neurosurg 114: 77-84 [CrossRef] [Google Scholar] [PubMed]
  14. Mills JD, Hadley K, Bailes JE (2011) Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery 68: 474-481 [CrossRef] [Google Scholar] [PubMed]
  15. Prins M (2008) Diet, ketones, and neurotrauma. Epilepsia 49: 111-113 [CrossRef] [Google Scholar] [PubMed]
  16. Shin SS, Dixon CE (2011) Oral fish oil restores striatal dopamine release after traumatic brain injury. Neurosci Lett 496: 168-171 [CrossRef] [Google Scholar] [PubMed]
  17. Petraglia AL, Winkler EA, Bailes JE (2011) Stuck at the bench: Potential natural Neuroprotective compounds for a concussion. Surg NeurolInt 2: 146 [CrossRef] [Google Scholar] [PubMed]
  18. National Research Council (2011) Nutrition and Traumatic Brain Injury: Improving Acute and Subacute Outcomes in Military Personnel. National Academies Press
  19. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, et al. (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J ClinNutr 71: 179S-188S [CrossRef] [Google Scholar] [PubMed]
  20. Raper NR, Cronin FJ, Exler J (1992) Omega-3 fatty acid content of the US food supply. J Am CollNutr 11: 304-308 [CrossRef] [Google Scholar] [PubMed]
  21. Tur JA, Bibiloni MM, Sureda A, Pons A (2012) Dietary sources of omega 3 fatty acids: public health risks and benefits. Br J Nutr 107: 23-52 [CrossRef] [Google Scholar] [PubMed]
  22. Innis SM (2003) Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 143: 1-8 [CrossRef] [Google Scholar] [PubMed]
  23. Innis SM (2007) Dietary (n-3) fatty acids and brain development. J Nutr 137: 855-859 [CrossRef] [Google Scholar] [PubMed]
  24. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP, et al. (2006) Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 84: 44-53 [CrossRef] [Google Scholar] [PubMed]
  25. Crawford MA (1993) The role of essential fatty acids in neural development: implications for perinatal nutrition. Am J Clin Nutr 57: 703S-709S [CrossRef] [Google Scholar] [PubMed]
  26. Singh M (2005) Essential fatty acids, DHA and the human brain. Indian J Pediatr 72: 239-242 [Google Scholar] [PubMed]
  27. Valentine RC, Valentine DL (2004) Omega-3 fatty acids in cellular membranes: a unified concept. Prog Lipid Res 43: 383-402 [CrossRef] [Google Scholar] [PubMed]
  28. Hering H, Lin CC, Sheng M (2003) Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23: 3262- 3271 [Google Scholar] [PubMed]
  29. Innis SM (2008) Dietary omega 3 fatty acids and the developing brain. Brain Res 1237: 35- 43 [CrossRef] [Google Scholar] [PubMed]
  30. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson EM Jr (2002) Lipid rafts in neuronal signaling and function. Trends Neurosci 25: 412-417 [CrossRef] [Google Scholar] [PubMed]
  31. Stillwell W, Wassall SR (2003) Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 126: 1-27 [CrossRef] [Google Scholar] [PubMed]
  32. Armstrong VT, Brzustowicz MR, Wassall SR, Jenski LJ, Stillwell W, et al. (2003) Rapid flip-flop in polyunsaturated (docosahexaenoic) phospholipid membranes. Arch Biochem Biophys 414: 74-82 [CrossRef] [Google Scholar] [PubMed]
  33. Chapkin RS, Wang N, Fan YY, Lupton JR, Prior IA, et al. (2008) Docosahexaenoic acid alters the size and distribution of cell surface microdomains. Biochim Biophys Acta 1778: 466-471 [CrossRef] [Google Scholar] [PubMed]
  34. Ehringer W, Belcher D, Wassall SR, Stillwell W (1990) A comparison of the effects of linolenic (18:3 omega 3) and docosahexaenoic (22:6 omega 3) acids on Phospholipid bilayers. Chem Phys Lipids 54: 79-88 [CrossRef] [Google Scholar] [PubMed]
  35. Huster D, Arnold K, Gawrisch K (1998) Influence of docosahexaenoic acid and cholesterol on lateral lipid organization in phospholipid mixtures. Biochemistry 37: 17299-17308 [CrossRef] [Google Scholar] [PubMed]
  36. Kafrawy O, Zerouga M, Stillwell W, Jenski LJ (1998) Docosahexaenoic acid inPhosphatidylcholine mediates cytotoxicity more effectively than other omega-3 and omega- 6 fatty acids. Cancer Lett 132: 23-29 [CrossRef] [Google Scholar] [PubMed]
  37. Salem N, Niebylski CD (1995) The nervous system has an absolute molecular species requirement for proper function. Mol Membr Biol 12: 131-134 [CrossRef] [Google Scholar] [PubMed]
  38. Smaby JM, Momsen MM, Brockman HL, Brown RE (1997) Phosphatidylcholine acyl unsaturation modulates the decrease in interfacial elasticity induced by cholesterol. Biophys J 73: 1492-1505 [CrossRef] [Google Scholar] [PubMed]
  39. Wassall SR, Stillwell W (2008) Docosahexaenoic acid domains: the ultimate non-raftMembrane domain. Chem Phys Lipids 153: 57-63 [CrossRef] [Google Scholar] [PubMed]
  40. Bazan NG (2005) Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol 15: 159-166 [CrossRef] [Google Scholar] [PubMed]
  41. Bazan NG, Musto AE, Knott EJ (2011) Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol 44: 216-222 [CrossRef] [Google Scholar] [PubMed]
  42. Niemoller TD, Stark DT, Bazan NG (2009) Omega-3 fatty acid docosahexaenoic acid is the precursor of neuroprotectin D1 in the nervous system. World Rev Nutr Diet 99: 46-54 [CrossRef] [Google Scholar] [PubMed]
  43. Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B, et al. (2012) Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protection formation. Prostaglandins Other Lipid Mediat 97: 73-82 [CrossRef] [Google Scholar] [PubMed]
  44. Tassoni D, Kaur G, Weisinger RS, Sinclair AJ (2008) The role of eicosanoids in the brain. Asia Pac J ClinNutr 1: 220-228 [Google Scholar] [PubMed]
  45. Im DS (2012) Omega-3 fatty acids in anti-inflammation (pro-resolution) and GPCRs. Prog Lipid Res 51: 232-237 [CrossRef] [Google Scholar] [PubMed]
  46. Ahmad A, Moriguchi T, Salem N (2002) Decrease in neuron size in the docosahexaenoic acid-deficient brain. Pediatr Neurol 26: 210-218 [CrossRef] [Google Scholar] [PubMed]
  47. Aid S, Vancassel S, Poumes-Ballihaut C, Chalon S, Guesnet P, et al. (2003) Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 44: 1545-1551 [CrossRef] [Google Scholar] [PubMed]
  48. Chalon S (2006) Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 75: 259-269 [CrossRef] [Google Scholar] [PubMed]
  49. Innis SM, Gilley J, Werker J (2001) Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants? J Pediatr 139: 532-538 [CrossRef] [Google Scholar] [PubMed]
  50. Wainwright RE, Bulman-fleming MB, Lévesque S, Mutsaers L, McCutcheon D, et al. (1998) A Saturated-Fat Diet during Development Alters Dendritic Growth in Mouse Brain. NutrNeurosci 1: 49-58 [CrossRef] [Google Scholar] [PubMed]
  51. He C, Qu X, Cui L, Wang J, Kang JX (2009) Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc Natl AcadSci USA 106: 11370-11375 [CrossRef] [Google Scholar] [PubMed]
  52. Farkas E, de Wilde MC, Kiliaan AJ, Luiten PG (2002) Systemic effects of dietary n-3 PUFA supplementation accompany changes of CNS parameters in cerebral hypoperfusion. Ann N Y Acad Sci 977: 77-86 [CrossRef] [Google Scholar] [PubMed]
  53. Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, et al. (2002) Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci 116: 1022-1031 [CrossRef] [Google Scholar] [PubMed]
  54. Bourre JM, Francois M, Youyou A, Dumont O, Piciotti M, et al. (1989) The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, theamplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J Nutr 119: 1880-1892 [CrossRef] [Google Scholar] [PubMed]
  55. Carrie I, Clement M, de Javel D, Frances H, Bourre JM, et al. (2000) Phospholipid supplementation reverses behavioral and biochemical alterations induced by an n-3polyunsaturated fatty acid deficiency in mice. J Lipid Res 41: 473-480 [Google Scholar] [PubMed]
  56. Yamamoto N, Hashimoto A, Takemoto Y, Okuyama H, Nomura M, et al. (1988) Effect of the dietary alpha-linolenic/linoleate balance on lipid compositions and learning the ability of rats. J Lipid Res 29: 1013-1021 [Google Scholar] [PubMed]
  57. Pan HC, Kao TK, Ou YC, Yang DY, Yen YJ, et al. (2009) Protective effect of docosahexaenoic acid against brain injury in ischemic rats. J Nutr Biochem 20: 715-725 [CrossRef] [Google Scholar] [PubMed]
  58. Suchy J, Chan A, Shea TB (2009) Dietary supplementation with a combination of alphalipoic acid, acetyl-L-carnitine, glycerophosphocholine, docosahexaenoic acid, andPhosphatidylserine reduces oxidative damage to the murine brain and improves cognitive Performance. Nutr Res 29: 70-74 [CrossRef] [Google Scholar] [PubMed]
  59. Bazan NG, Molina MF, Gordon WC (2011) Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu Rev Nutr 31: 321-351 [CrossRef] [Google Scholar] [PubMed]
  60. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, et al. (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6: 456-464 [CrossRef] [Google Scholar] [PubMed]
  61. Bistrian BR, Askew W, Erdman JW Jr, Oria MP (2011) Nutrition and traumatic brain injury: a perspective from the Institute of Medicine report. JPEN J Parenter EnteralNutr 35: 556-559 [CrossRef] [Google Scholar] [PubMed]
  62. Garbagnati F, Cairella G, De Martino A, Multari M, Scognamiglio U, et al. (2009) Is antioxidant and n-3 supplementation able to improve functional status inpost stroke patients? Results from the Nutristroke Trial. Cerebrovasc Dis 27: 375-383 [CrossRef] [Google Scholar] [PubMed]
  63. Poppitt SD, Howe CA, Lithander FE, Silvers KM, Lin RB, et al. (2009) Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlled trial. Stroke 40: 3485-3492 [CrossRef] [Google Scholar] [PubMed]
  64. Yoneda H, Shirao S, Kurokawa T, Fujisawa H, Kato S, et al. (2008) Doeseicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmalsubarachnoid hemorrhage? Acta Neurol Scand 118: 54-59 [CrossRef] [Google Scholar] [PubMed]
  65. Cao DH, Xu JF, Xue RH, Zheng WF, Liu ZL, et al. (2004) Protective effect of chronic ethyl docosahexaenoate administration on brain injury in ischemic gerbils. Pharmacol Biochem Behav 79: 651-659 [CrossRef] [Google Scholar] [PubMed]
  66. Green P, Glozman S, Weiner L, Yavin E, et al. (2001) Enhanced free radical scavenging and decreased lipid peroxidation in the rat fetal brain after treatment with ethyl docosahexaenoate. Biochim Biophys Acta 1532: 203- 212 [CrossRef] [Google Scholar] [PubMed]
  67. Okada M, Amamoto T, Tomonaga M, Kawachi A, Yazawa K, et al. (1996) The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficitfollowing transient forebrain ischemia in rats. Neuroscience 71: 17-25 [CrossRef] [Google Scholar] [PubMed]
  68. Stratton RJ, King C, Elia M (2004) Simple cost-analysis of changes in hospitallength of stay with oral nutritional supplements from randomized controlledtrials. Clin Nutr 23: 906-915
  69. Bassey EJ (1986) Demi-span as a measure of skeletal size. Ann Hum Biol 13: 499- 502 [CrossRef] [Google Scholar] [PubMed]
  70. Lim SL, Ong KC, Chan YH, LoceWC, Ferguson M, et al. Malnutrition and its impact on the cost of hospitalization, length of stay, readmission and 3- years mortality. Clin Nutr 31: 345-350 [CrossRef] [Google Scholar] [PubMed]
  71. Report of the Panel on Macronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, andamino acids (macronutrients) (2005) Washington, DC: National Academies Press
  72. Ahuja JKA, Montville JB, Omolewa-Tomobi G, Heendeniya KY, Martin CL, et al. (2012) USDA Food and Nutrient Database for Dietary Studies, 5.0. USDA, Agricultural Research Service, Food Surveys Research Group, Beltsville, MD
  73. IOM (2005) Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). Washington, DC: The National Academies Press
  74. Niemoller TD, Stark DT, Bazan NG (2009) Omega-3 fatty acid docosahexaenoic acid Is the precursor of neuroprotectin D1 in the nervous system. World Rev Nutr Diet 99: 46-54 [CrossRef] [Google Scholar] [PubMed]
  75. Hasadsri L, Wang BH, Lee JV, Erdman JW, Llano DA, et al. (2013) Omega-3 fatty acids as a putative treatment for traumatic brain injury. J Neurotrauma 30: 897-906 [CrossRef] [Google Scholar] [PubMed]
  76. Michael-Titus AT, Priestley JV (2014) Omega-3 fatty acids and traumatic neurological injury: from neuroprotection to neu- roplasticity? Trends Neurosci 37: 30-38 [CrossRef] [Google Scholar] [PubMed]
  77. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, et al. (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6: 456-464 [CrossRef] [Google Scholar] [PubMed]
  78. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E, et al. (2002) Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75: 689-697 [CrossRef] [Google Scholar] [PubMed]
  79. Hasadsri L, Wang BH, Lee JV, Erdman JW, Llano DA, et al. (2013) Omega-3 Fatty Acids as a Putative Treatment for Traumatic Brain Injury. Journal of Neurotrauma 30: 897-906 [CrossRef] [Google Scholar] [PubMed]
  80. McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, et al. (2009) Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 33: 277-316 [CrossRef] [PubMed]
  81. Siobhan M (2014) The Glasgow Coma Scale 40 years on a review of its practical use. British Journal of Neuroscience Nursing [CrossRef] [Google Scholar]
  82. Juliet F, Claranne M (2001) The History of the Glasgow Coma Scale: Implications for Practice. Critical Care Nurse 23: 52-58 [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.